{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:58:12Z","timestamp":1774958292106,"version":"3.50.1"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1186492"],"award-info":[{"award-number":["1186492"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis Journal \u2013 Experimental, Translational and Clinical"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This scoping review aimed to identify existing information and gaps in knowledge regarding the diversity characteristics of the multiple sclerosis (MS) population in Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE, EMBASE, Cumulated Index in Nursing and Allied Health Literature (CINAHL), SCOPUS and ProQuest's global dataset of theses and dissertations from 2010 to January 12, 2024. Data sources were case reports\/series, cohort studies, case-control studies, analytical cross-sectional studies, randomized clinical trials, qualitative, mixed methods, participatory studies and systematic reviews conducted in Canada, published in English or French, that included participants with clinically isolated syndrome or MS. Sample characteristics were extracted applying Cochrane's PROGRESS-Plus framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 259 studies, most often studying disease-modifying therapy (24.3%) and access to care (20.9%). Among primary data collection studies 40% used one recruitment strategy, usually MS Clinics and MS Canada. Age (92.7%) and sex (86.9%) were reported most often, \u226410% of studies reported race or ethnicity; religion, sexual orientation and language were not reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We lack an understanding of characteristics of people living with MS in Canada relevant to health equity. Existing research has been insufficiently inclusive. Better reporting of diversity characteristics is needed, along with specific efforts to recruit and retain more diverse samples.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20552173251321814","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:46:41Z","timestamp":1742212001000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-5595","authenticated-orcid":false,"given":"Ruth Ann","family":"Marrie","sequence":"first","affiliation":[{"name":"Dalhousie University"},{"name":"University of Manitoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-5782","authenticated-orcid":false,"given":"Afolasade","family":"Fakolade","sequence":"additional","affiliation":[{"name":"Queen's University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-9022","authenticated-orcid":false,"given":"Janice","family":"Linton","sequence":"additional","affiliation":[{"name":"University of Manitoba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-2899","authenticated-orcid":false,"given":"Colleen J.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"University of Waterloo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-3684","authenticated-orcid":false,"given":"Dalia","family":"Rotstein","sequence":"additional","affiliation":[{"name":"University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8000-1998","authenticated-orcid":false,"given":"Brayden","family":"Schindell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-2535","authenticated-orcid":false,"given":"Helen","family":"Tremlett","sequence":"additional","affiliation":[{"name":"University of British Columbia and The Djavad Mowafaghian Centre for Brain Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-7417","authenticated-orcid":false,"given":"Ann","family":"Yeh","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children"},{"name":"University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-4810","authenticated-orcid":false,"given":"Marcia","family":"Finlayson","sequence":"additional","affiliation":[{"name":"Queen's University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.12.1686"},{"key":"e_1_3_3_3_2","first-page":"205521731666609","article-title":"Multiple sclerosis in First Nations Canadians: a pilot comparison study","volume":"2","author":"Marrie RA","year":"2016","unstructured":"Marrie RA, Hall N, Sadovnick AD. Multiple sclerosis in First Nations Canadians: a pilot comparison study. Mult Scler - ETC 2016; 2: 2055217316666093.","journal-title":"Mult Scler - ETC"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007190"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234876"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.3416"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211031791"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512436595"},{"key":"e_1_3_3_9_2","first-page":"3","article-title":"Multiple sclerosis: prevalence and impact","volume":"29","author":"Gilmour H","year":"2018","unstructured":"Gilmour H, Ramage-Morin PL, Wong SL. Multiple sclerosis: prevalence and impact. Health Rep 2018; 29: 3\u20138.","journal-title":"Health Rep"},{"key":"e_1_3_3_10_2","article-title":"Enrollment of non-white participants and reporting of race and ethnicity in phase III trials of multiple sclerosis DMTs","volume":"98","author":"Onuorah H-M","year":"2022","unstructured":"Onuorah H-M, Charron O, Meltzer E, et al. Enrollment of non-white participants and reporting of race and ethnicity in phase III trials of multiple sclerosis DMTs. A Systematic Review 2022; 98: e880\u2013ee92.","journal-title":"A Systematic Review"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231189670"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104606"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231189677"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000277"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00735-5"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.812147"},{"key":"e_1_3_3_19_2","unstructured":"Campbell S. Filter to Retrieve Studies Related to Canada and Canadian Provinces from OVID MEDLINE. Geoffrey & Robyn Sperber Health Sciences Library University of Alberta. 2022."},{"key":"e_1_3_3_20_2","unstructured":"Kung J. Filter to Retrieve Studies Related to Canada and Canadian Provinces from CINAHL. Geoffrey & Robyn Sperber Health Sciences Library University of Alberta. 2022."},{"key":"e_1_3_3_21_2","unstructured":"Campbell S. Filter to Retrieve Studies Related to Canada and Canadian Provinces from OVID EMBASE. Geoffrey & Robyn Sperber Health Sciences Library University of Alberta. 2022."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221126380"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.16274"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1177020"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.005"},{"key":"e_1_3_3_28_2","unstructured":"Kavanaugh J Oliver S Lorenc T. Reflections on developing and using PROGRESS-plus. Equity Update. Cochrane Health Equity Field and Campbell Equity Methods Group 2008; 2: 1\u20133."},{"key":"e_1_3_3_29_2","unstructured":"Wells G Shea B O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (accessed November 12 2023)."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033509"},{"key":"e_1_3_3_31_2","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J 2019; 366: l4898.","journal-title":"Br Med J"},{"key":"e_1_3_3_32_2","unstructured":"Critical Appraisal Skills Programme. CASP (Qualitative) Checklist: (2018 accessed November 19 2023)."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000062"},{"key":"e_1_3_3_34_2","first-page":"1752\u20133j","article-title":"Cohort profile: the Canadian Longitudinal Study on Aging (CLSA)","volume":"48","author":"Raina P","year":"2019","unstructured":"Raina P, Wolfson C, Kirkland S, et al. Cohort profile: the Canadian Longitudinal Study on Aging (CLSA). Int J Epidemiol 2019; 48: 1752\u20133j.","journal-title":"Int J Epidemiol"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011219"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.754144"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200163"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043930"},{"key":"e_1_3_3_39_2","article-title":"Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada\u2019s population","author":"Yusuf FLA","unstructured":"Yusuf FLA, Asaf A, Marrie RA, et al. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada\u2019s population. J Neurol Neurosurg Psychiatry 2024; 95: 229\u2013234.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.12.030"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.01.022"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.101987"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000495"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.05.010"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000418"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.08.013"}],"container-title":["Multiple Sclerosis Journal \u2013 Experimental, Translational and Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20552173251321814","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20552173251321814","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20552173251321814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:13:36Z","timestamp":1767680016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20552173251321814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1177\/20552173251321814"],"URL":"https:\/\/doi.org\/10.1177\/20552173251321814","relation":{},"ISSN":["2055-2173","2055-2173"],"issn-type":[{"value":"2055-2173","type":"print"},{"value":"2055-2173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"20552173251321814"}}